Drugs, ligation or both for the prevention of variceal rebleeding?

Gut

Volumn 58, Issue 8, 2009, Pages 1045-1046

  Schepke, Michael ^a  

^a Helios Pediatric Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL;

BLEEDING; CLINICAL DECISION MAKING; CLINICAL TRIAL; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES; HEMODYNAMICS; HUMAN; LIGATION; LIVER CIRRHOSIS; NOTE; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROPHYLAXIS; RISK; ULCER; VARICEAL REBLEEDING;

ADRENERGIC BETA-ANTAGONISTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIGATION; RECURRENCE; VASODILATOR AGENTS;

EID: 67650248683     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.177964     Document Type: Note

References (10)

1. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy of portal hypertension. J Hepatol 2005;43:167-76.
2. Gonzales R, Zamora J, Gomez-Camarero J, et al. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008;149:109-22
3. Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000;32:461-5
4. de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005;41:572-8
5. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-55
6. Patch D, Sabin C, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-9
7. Lo GH, Chen WC, Chen MH, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002;123:728-34
8. Romero G, Kravetz D, Argonz J, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 2006;24:601-11
9. Lo GH, Chen WC, Lin CK, et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 2008;48:580-7
10. Garcia-Pagan JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of variceal rebleeding: a multicentre randomised controlled trial. Gut 2009;58:1144-50.